C-Peptide Protein (full length)
宿主: 人
宿主: Human
Synthetic
> 98 % pure
-
- 抗原 See all C-Peptide 蛋白
- C-Peptide
- 蛋白类型
- Synthetic
- 产品特性
- full length
-
宿主
- 人
-
资源
- Human
- 序列
- Arg-Arg-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-Lys-Arg
- 产品特性
-
Purified recombinant Human C Peptide protein
Protein Source: Human (full length synthetic C-peptide) Tyr-C-Peptide - 纯化方法
- purified
- 纯度
- > 98 % pure
- Top Product
- Discover our top product C-Peptide 蛋白
-
-
- 应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 缓冲液
- Supplied as a lyophilized powder purified by HPLC, tyrosine residue.
- 注意事项
- Avoid repeated freeze/thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- Aliquot and store at -20 °C.
-
- 抗原
- C-Peptide
- 别名
- C Peptide (C-Peptide 产品)
- 背景
-
Proinsulin C-peptide was first described in 1967 in connection with the discovery of the insulin biosynthesis. It serves as an important linker between the A- and the B- chains of insulin and facilitates the efficient assembly, folding, and processing of insulin in the endoplasmic reticulum. Equimolar amounts of C-peptide and insulin are then stored in secretory granules of the pancreatic beta cells and both are eventually released to the portal circulation. Initially, the sole interest in C-peptide was as a marker of insulin secretion and has as such been of great value in furthering the understanding of the pathophysiology of type 1 and type 2 diabetes. The first documented use of the C-peptide test was in 1972. During the past decade, however, C-peptide has been found to be a bioactive peptide in its own right, with effects on microvascular blood flow and tissue health.
Description: Human (full length synthetic C-peptide) Tyr-C-Peptide.
Alternative Names: Proinsulin connecting peptide, C-Peptide protein - 分子量
- 3616.99 kDa
-
You are here:
